[RESEARCH BLOG] · 2026-08-07
RYTHM, Inc. (RYM) – Recovery‑Phase Buy Signal Amid THC‑Beverage Expansion and Volatile Valuation
By Pierre Brunelle · Founder & Research Lead
RYM closed at $22.08, down 11.64 % on the Thursday, 2026‑08‑06 session. The LOPJLB signal engine has just flipped the directional flag to BUY with a maximum score of 5 while the broader market pulse sits in a short‑term RECOVERY regime.
RYTHM, Inc. (NASDAQ:RYM) has been thrust into the spotlight by a flurry of corporate announcements over the past month. The company disclosed its second‑quarter 2026 results on August 4, reported a 14 % intraday rally on the same day, and highlighted a high‑visibility partnership that placed its “Señorita” THC‑infused beverage at Lollapalooza. These developments collectively sharpen the narrative around a nascent growth trajectory in the fast‑moving cannabis‑beverage niche.
Recent News / Catalysts
- RYTHM, Inc. Reports Second Quarter 2026 Results – GlobeNewswire, 2026‑08‑04 07:00:00
- RYTHM (NASDAQ:RYM) Trading Up 14% – Time to Buy? – DefenseWorld, 2026‑08‑04 02:22:00
- Señorita Brings THC Beverages to Lollapalooza for the First Time – GlobeNewswire, 2026‑07‑23 07:00:00
- Señorita Named Official THC Beverage Partner of Opry Entertainment Group Venues – GlobeNewswire, 2026‑05‑14 07:00:00
- Navy Pier Names RYTHM as Its Official THC Beverage Partner – GlobeNewswire, 2026‑05‑08 11:00:00
Earlier, on July 23, GlobeNewswire announced that Señorita would be served for the first time at the Lollapalooza music festival, marking the brand’s entry into a major cultural platform. In May, the company secured two high‑profile venue partnerships: an exclusive THC‑beverage deal with Opry Entertainment Group venues (May 14) and a naming agreement with Chicago’s Navy Pier (May 8). These venue contracts are designed to increase consumer exposure and reinforce brand positioning in premium entertainment settings.
Fundamentals and Valuation
RYM’s balance sheet and income statement remain a study in contrast. The trailing twelve‑month (TTM) price‑to‑earnings ratio sits at ‑2.14, reflecting a loss‑making profile that is common among emerging cannabis‑focused firms. The enterprise‑value‑to‑EBITDA multiple is similarly negative at ‑10.95, underscoring that operating cash flow remains in the negative zone despite a dramatic revenue uptick.
Margins tell a more nuanced story. Gross profit margins have climbed to 68.43 %, a substantial improvement from the sub‑10 % levels recorded in 2020‑2022. This swing is largely attributable to the higher‑margin THC‑beverage segment, which commands premium pricing. However, operating margins are still deeply in the red at ‑30.32 %, and net margins sit at ‑6.20 %, indicating that SG&A and R&D expenses continue to outpace top‑line growth. The free‑cash‑flow (FCF) yield of 4.93 % suggests modest cash generation relative to market capitalization, though the absolute FCF remains negative.
Return metrics are likewise mixed. Return on invested capital (ROIC) is ‑7.57 %, and return on equity (ROE) is ‑10.54 %, both reflecting the company’s ongoing capital‑intensive expansion. The return on assets (ROA) of ‑2.34 % mirrors the broader profitability challenges. The debt‑to‑equity ratio is elevated at 206.3 %, highlighting a capital structure that leans heavily on borrowed funds—a typical feature for micro‑caps in the cannabis space that are financing rapid growth.
Below is a snapshot of the most salient valuation and profitability metrics:
| Metric | Value |
|---|---|
| P/E (TTM) | ‑2.14 |
| EV/EBITDA | ‑10.95 |
| P/B | 1.22 |
| P/FCF | 20.27 |
| Gross Margin | 68.43 % |
| Operating Margin | ‑30.32 % |
| Net Margin | ‑6.20 % |
| FCF Yield | 4.93 % |
| Debt/Equity | 206.3 % |
Multi‑Year Performance Context
RYM’s historical financial trajectory underscores the volatility inherent in the cannabis‑beverage niche. In 2020 the company posted $12.09 M in revenue with a net loss per share of ‑$3,195.4, and a negative free‑cash‑flow of ‑$14.92 M. By the end of 2021, revenue had nearly quintupled to $59.86 M, yet earnings per share (EPS) deteriorated further to ‑$4,394, and free cash flow deepened to ‑$32.47 M. The 2022 year‑end figures show a modest revenue contraction to $58.26 M, but an alarming swing in gross margin to ‑54.58 % and a net loss per share of ‑$13,532.
A turnaround began in 2023, when revenue fell to $15.14 M—a sharp decline that reflected a strategic pivot toward higher‑margin THC beverages—while gross margins rebounded to 17.88 %. The net loss narrowed to ‑$187.6 per share, and free cash flow remained negative at ‑$31.03 M. In 2024, revenue slipped further to $9.68 M, but the gross margin held at 6.87 %, indicating that the company retained a core of profitable product lines despite a shrinking top line. By the close of 2025, revenue climbed back to $17.28 M, and the gross margin surged to 58.96 %, the highest level in the six‑year window. EPS improved to ‑$16.68, still negative but markedly better than the double‑digit losses of prior years. Free cash flow remained in deficit (‑$23.54 M), reflecting ongoing investment in brand development and distribution.
The revenue growth figure of 1027.4 % reported for the latest quarter is a year‑over‑year metric that captures the impact of newly signed licensing agreements and the expansion of the Señorita brand into high‑traffic venues. While the absolute revenue number for Q2 2026 has not been disclosed in the press release, the percentage growth suggests that the company may be moving from a low‑base to a scale‑up phase.
ETF Ownership
RYM’s float is modest, with a market capitalization of $47.5 M, and it is held by a narrow set of exchange‑traded funds. The two largest ETF holders are:
Concentrated ETF ownership can amplify price movements when fund managers rebalance or adjust sector allocations, especially in micro‑cap stocks where a few percent of float translates to a sizable share of daily trading volume. The presence of the OLD fund at nearly 3 % of the float suggests that institutional sentiment, albeit limited, may provide a modest floor of liquidity during periods of heightened volatility.
LOPJLB Signal Read
The LOPJLB engine has issued a BUY directional signal for RYM, placing the stock in a RECOVERY market regime that has persisted for three days. The composite PERF score of 5.10 and the FUND quality score of 19.78 reinforce the view that the stock is exhibiting favorable momentum while maintaining a baseline of quality relative to peers. The growth‑oriented metrics dominate the profile: a Growth score of 58.00, a GARP score of 24.80, and a Value score of 0.00, classifying RYM as a Growth Compounder archetype.
Investors can explore the interactive chart above on the RYM stock page to visualize the overlay of technical signals, including EMA crossovers and breadth acceleration that underpin the current BUY stance. For a deeper dive into the methodology that generates these signals, consult LOPJLB’s methodology page.
Explore further:
- Detailed stock profile: https://www.lopjlb.com/stock/RYM
- Earnings archive (if applicable): https://www.lopjlb.com/stock/RYM/earnings.md
- Full‑screen screener for similar micro‑cap growth compounds: https://www.lopjlb.com/screener
The information presented here is for research purposes only and does not constitute investment advice. All investors should conduct their own due diligence and consider their risk tolerance before making any trading decisions.
This post is independent quantitative research, not investment advice. LOPJLB signals are model outputs derived from price, volume, and fundamentals. Past backtests do not guarantee future results. Position sizing, execution, and risk management remain the reader's responsibility.